SCHEMBL29130528

SCHEMBL29130528

CCOC(=O)C(OC(=O)CC(=O)CC(=O)O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 2/20 0.48
SMN1; SMN2 Q16637 3/20 0.43
ALDH1A1 P00352 5/20 0.42
TSHR P16473 1/20 0.42
KDM4E B2RXH2 3/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
RECQL P46063 1/20 0.41
HPGD P15428 2/20 0.41
GAA P10253 1/20 0.41
PIN1 Q13526 1/20 0.41
CASR P41180 1/20 0.41
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPT P10636 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30601599 1.00 MMP8 (0.48) MMP8SMN1; SMN2ALDH1A1TSHRKDM4E
SCHEMBL29130527 0.96 MMP8 (0.51) MMP8SMN1; SMN2ALDH1A1TSHRKDM4E
SCHEMBL30601600 0.88 KMT2A (0.49) SMN1; SMN2ALDH1A1TSHRLMNAMEN1
SCHEMBL29130537 0.88 KMT2A (0.49) SMN1; SMN2ALDH1A1TSHRLMNAMEN1
SCHEMBL280062 0.85 MMP8 (0.50) MMP8SMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL28731165 0.85 MMP8 (0.50) MMP8SMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL29130535 0.83 KMT2A (0.53) SMN1; SMN2ALDH1A1TSHRLMNAMEN1
SCHEMBL28278094 0.83 MMP8 (0.50) MMP8SMN1; SMN2ALDH1A1TSHRKDM4E
SCHEMBL30595396 0.81 SMN1; SMN2 (0.52) MMP8SMN1; SMN2ALDH1A1TSHRKDM4E
SCHEMBL28555706 0.79 TSHR (0.57) MMP8SMN1; SMN2ALDH1A1TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114349687-B 3, 5-dicarboxylic ester-1, 4-dihydropyridine hydrogenation reagent, preparation method and application thereof 中山奕安泰医药科技有限公司 2023-11-17 CN disclosed